title: Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors.
abstract: BACKGROUND
  Substantial increases in body weight can be induced by several antipsychotic drugs, most notably olanzapine and clozapine. Antagonism at certain receptors, particularly 5-HT2C and histamine H1 receptors, is implicated in this effect.
  
  
  METHODS
  We have investigated the contribution of effects at these receptors to olanzapine-induced weight gain occurring over 5 days following daily intraperitoneal drug injections in groups of eight female rats.
  
  
  RESULTS
  Olanzapine (2 mg/kg) and the 5-HT2C antagonist SB 243213 (1 mg/kg), but not the histamine H1 antagonist mepyramine (1 mg/kg), produced significant increases in percentage body weight above vehicle; olanzapine showed a significantly greater effect than SB 243213. Haloperidol (0.1 mg/kg) alone or with mepyramine had no significant effects on weight gain, while with SB 243213 and with both SB 243213 and mepyramine, it showed olanzapine-like increases in weight.
  
  
  CONCLUSIONS
  These results suggest that 5-HT2C receptor antagonism or inverse agonism, in the presence of D2 receptor antagonism, may contribute to olanzapine-induced weight gain.
authors.affiliation: Department of Psychiatry, Queen's University Belfast, Whitla Medical Building, 97 Lisburn Road, Belfast, BT9 7BL, UK.
authors.forename: Shona L
authors.initials: SL
authors.lastname: Kirk
authors.forename: John
authors.initials: J
authors.lastname: Glazebrook
authors.forename: Ben
authors.initials: B
authors.lastname: Grayson
authors.forename: Joanna C
authors.initials: JC
authors.lastname: Neill
authors.forename: Gavin P
authors.initials: GP
authors.lastname: Reynolds
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001569:Benzodiazepines / Q000494:pharmacology*; D018492:Dopamine Antagonists / Q000494:pharmacology; D004347:Drug Interactions; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D000077152:Olanzapine; D011725:Pyridines / Q000494:pharmacology; D011738:Pyrilamine / Q000494:pharmacology; D051381:Rats; D044405:Receptor, Serotonin, 5-HT2C / Q000502:physiology*; D011969:Receptors, Histamine H1 / Q000502:physiology*; D058826:Serotonin 5-HT2 Receptor Agonists; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology*; D013997:Time Factors; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D001569:Benzodiazepines; D018492:Dopamine Antagonists; D006220:Haloperidol; D006634:Histamine H1 Antagonists; D007211:Indoles; D000077152:Olanzapine; D011725:Pyridines; D011738:Pyrilamine; D044405:Receptor, Serotonin, 5-HT2C; D011969:Receptors, Histamine H1; D058826:Serotonin 5-HT2 Receptor Agonists; D017367:Selective Serotonin Reuptake Inhibitors; C406343:SB 243213
references.citation: Psychopharmacology (Berl). 1996 Mar;124(1-2):57-73
references.pmid: 8935801
references.citation: J Clin Psychiatry. 1999 Jun;60(6):358-63
references.pmid: 10401912
references.citation: Neuropharmacology. 2006 Jun;50(8):953-63
references.pmid: 16549074
references.citation: Psychoneuroendocrinology. 2008 Jun;33(5):569-80
references.pmid: 18358632
references.citation: Appetite. 2006 May;46(3):254-62
references.pmid: 16551485
references.citation: Pharmacol Biochem Behav. 1996 Jan;53(1):221-6
references.pmid: 8848454
references.citation: Pharmacol Biochem Behav. 1998 Mar;59(3):753-8
references.pmid: 9512082
references.citation: Am J Psychiatry. 1999 Nov;156(11):1686-96
references.pmid: 10553730
references.citation: Eur J Pharmacol. 2004 Nov 28;505(1-3):253-4
references.pmid: 15556160
references.citation: J Pharmacol Exp Ther. 2001 Oct;299(1):83-9
references.pmid: 11561066
references.citation: J Psychopharmacol. 2007 Jun;21(4):405-13
references.pmid: 17050655
references.citation: Psychopharmacology (Berl). 2007 Oct;194(2):221-31
references.pmid: 17581744
references.citation: J Pharmacol Exp Ther. 2006 Oct;319(1):260-8
references.pmid: 16807362
references.citation: Psychopharmacology (Berl). 2000 Oct;152(3):256-67
references.pmid: 11105935
references.citation: Am J Physiol. 1989 Mar;256(3 Pt 2):R605-11
references.pmid: 2564258
references.citation: Drug Saf. 2001 Jan;24(1):59-73
references.pmid: 11219487
references.citation: Obesity (Silver Spring). 2006 Jan;14(1):36-51
references.pmid: 16493121
references.citation: Br J Pharmacol. 1997 Aug;121(8):1613-8
references.pmid: 9283694
references.citation: Neuropharmacology. 1997 Apr-May;36(4-5):621-9
references.pmid: 9225287
references.citation: J Psychopharmacol. 2008 Jul;22(5):567-71
references.pmid: 18208914
references.citation: Psychopharmacology (Berl). 2005 Oct;182(2):220-31
references.pmid: 16001110
references.citation: J Psychopharmacol. 2004 Sep;18(3):340-5
references.pmid: 15358977
references.citation: Lancet. 2001 Feb 3;357(9253):354-7
references.pmid: 11210998
references.citation: Brain Res. 1988 Feb 16;441(1-2):403-7
references.pmid: 3359243
references.citation: J Psychopharmacol. 2004 Jun;18(2):149-55
references.pmid: 15260902
references.citation: Neuropsychopharmacology. 2003 Mar;28(3):519-26
references.pmid: 12629531
references.citation: J Pharmacol Exp Ther. 2000 Oct;295(1):226-32
references.pmid: 10991983
references.citation: Brain Res Bull. 1985 Oct;15(4):385-9
references.pmid: 2933127
references.citation: Neuropharmacology. 1997 Apr-May;36(4-5):609-20
references.pmid: 9225286
references.citation: Pharmacol Biochem Behav. 1987 Jul;27(3):399-405
references.pmid: 2889218
references.citation: Behav Pharmacol. 2008 Mar;19(2):121-8
references.pmid: 18332676
references.citation: Neuropharmacology. 2001 Aug;41(2):186-99
references.pmid: 11489455
references.citation: Drug Metab Pharmacokinet. 2005 Oct;20(5):368-78
references.pmid: 16272755
references.citation: Eur Neuropsychopharmacol. 2004 Oct;14(5):385-92
references.pmid: 15336300
references.citation: Psychopharmacology (Berl). 2005 Aug;181(1):80-9
references.pmid: 15778884
references.citation: Psychopharmacology (Berl). 2005 Mar;178(2-3):241-9
references.pmid: 15719229
references.citation: Pharmacol Biochem Behav. 2003 Sep;76(2):251-8
references.pmid: 14592676
references.citation: Physiol Behav. 1988;44(4-5):599-606
references.pmid: 3237847